Menotrophin, HMG (as FSH + LH)
Indications
Menotrophin, HMG (as FSH + LH) is used for:
CHORIONIC GONADOTROPIN (HUMAN)
For the treatment of prepubertal cryptorchidism (not due to anatomical obstruction), for the treatment of selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males and for the induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with human menotropins
CHORIONIC GONADOTROPIN (RECOMBINANT)
For the treatment of female infertility
For the treatment of prepubertal cryptorchidism (not due to anatomical obstruction), for the treatment of selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males and for the induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with human menotropins
CHORIONIC GONADOTROPIN (RECOMBINANT)
For the treatment of female infertility
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Menotrophin, HMG (as FSH + LH) :
Mechanism of Action
CHORIONIC GONADOTROPIN (RECOMBINANT)
Choriogonadotropin alfa binds to the follicle stimulating hormone receptor which results in ovulation in the absence of sufficient endogenous luteinizing hormone
Choriogonadotropin alfa binds to the follicle stimulating hormone receptor which results in ovulation in the absence of sufficient endogenous luteinizing hormone